What is the global market size of Organ Preservation Market?

Organ Preservation Market size was valued at USD 230.89 million in 2021 and is poised to grow from USD 246.64 million in 2022 to USD 410.24 million by 2030, growing at a CAGR of 6.8% in the forecast period (2023-2030).

Who are the key vendors in the Global Organ Preservation Market?

The global organ preservation market is relatively fragmented, with a high level of competition. The prominent players operating in the market are constantly adopting various growth strategies to stay afloat in the market. Product launches, innovations, mergers, and acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these key players to thrive in the competitive market. The key market players are also constantly focused on R&D to supply industries with the most efficient and cost-effective solutions. 'Organ Recovery Systems', 'XVIVO Perfusion', 'Paragonix Technologies', 'Bridge to Life', 'TransMedics', 'Preservation Solutions Inc.', '21st Century Medicine', 'Dr. Franz Köhler Chemie GmbH', 'BioLife Solutions Inc.', 'Waters Medical Systems LLC', 'IGL Transplantation Services', 'CryoLife', 'Lifeline Scientific', 'Cytosol Laboratories Inc.', 'Lifor Medtech', 'Scinovia Corporation', 'Teva Pharmaceutical Industries Ltd.', 'OrganOx', 'Organ Assist', 'Organ Transport Systems Inc.', 'In August 2021, he LIVERguard Donor Liver Preservation System was introduced by Paragonix Technologies in the US and Europe. This tactic boosted Paragonix's global footprint and broadened their range of products.', 'In June 2021, in order to grow its company and have access to a wide network of transplantation clinics in Brazil, the biggest nation in Latin America, XVIVO Perfusion teamed with Contatti Medical (Brazil.'.

What is the key driver of Global Organ Preservation Market?

One of the most frequent causes of mortality in ICUs is multiple organ failure, which is mostly brought on by sepsis. According to estimates, up to 20% of individuals with sepsis exhibit acute respiratory failure and 26–50% develop acute renal failure (Society of Critical Care Medicine). Acute renal failure is more common in the elderly due to age-related declines in renal plasma flow and glomerular filtration rate. Diabetes makes people more susceptible to both of these diseases and multiple organ failure. Geriatric patients are more likely to have illnesses including TB and liver cirrhosis, which may necessitate organ transplantation.

What is the key market trend for Global Organ Preservation Market?

To provide better healthcare services, governments all around the world are concentrating on bolstering their healthcare infrastructures. For instance, the Brihanmumbai Municipal Corporation in India set aside around USD 924 million (INR 7,000 crore), or 15% of its budget for 2022–2023, to improve health services and create 100 health clinics with more than 100 diagnostic tests for preventative and primary treatment in BMC regions. There will be more hospitals that handle more brain-dead people who could make good donors as a result of these infrastructure upgrades. The time involved with donor-recipient cross-matching, subject profiling, genotyping, and other associated diagnostic tests during the pre-transplantation phase will also be improved by the growth in testing labs. It is anticipated that these discoveries would open up new potential for the organ preservation sector.

Which region accounted for the largest share in Global Organ Preservation Market?

In 2021, North America accounted for the biggest market share, and it is anticipated that it will continue to dominate over the projected period. The main drivers of growth are the increasing adoption of cutting-edge healthcare technology, the high prevalence of chronic renal disease and heart failure, improved reimbursement rules, and rising investments in expanding healthcare infrastructure. The regional market is also anticipated to rise as a result of the ageing population and an increase in organ transplant surgeries.

Top Organ Preservation Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Organ Preservation Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Organ Preservation industry players.

Organ Preservation Market Competitive Landscape

The global organ preservation market is relatively fragmented, with a high level of competition. The prominent players operating in the market are constantly adopting various growth strategies to stay afloat in the market. Product launches, innovations, mergers, and acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these key players to thrive in the competitive market. The key market players are also constantly focused on R&D to supply industries with the most efficient and cost-effective solutions.

Top Player in the Global Organ Preservation Market

Organ Recovery Systems
XVIVO Perfusion
Paragonix Technologies
Bridge to Life
TransMedics
Preservation Solutions Inc.
21st Century Medicine
Dr. Franz Köhler Chemie GmbH
BioLife Solutions Inc.
Waters Medical Systems LLC
IGL Transplantation Services
CryoLife
Lifeline Scientific
Cytosol Laboratories Inc.
Lifor Medtech
Scinovia Corporation
Teva Pharmaceutical Industries Ltd.
OrganOx
Organ Assist
Organ Transport Systems Inc.

Organ Preservation Market Recent Developments

In August 2021, he LIVERguard Donor Liver Preservation System was introduced by Paragonix Technologies in the US and Europe. This tactic boosted Paragonix's global footprint and broadened their range of products.
In June 2021, in order to grow its company and have access to a wide network of transplantation clinics in Brazil, the biggest nation in Latin America, XVIVO Perfusion teamed with Contatti Medical (Brazil.

REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?

REQUEST FREE CUSTOMIZATION

FAQs

Organ Preservation Market size was valued at USD 263.41 Million in 2024 and is poised to grow from USD 281.32 Million in 2025 to USD 476.19 Million by 2033, growing at a CAGR of 6.8% during the forecast period (2026–2033).

Key vendors in the Organ Preservation Market include Organ Recovery Systems, XVIVO Perfusion, Paragonix Technologies, Bridge to Life, TransMedics, Preservation Solutions, 21st Century Medicine, Dr. Franz Köhler Chemie, BioLife Solutions, Lifeline Scientific, and OrganOx.

The key driver of the Organ Preservation Market is the rising prevalence of chronic diseases and organ failure, particularly liver and kidney failure, which is increasing demand for organ transplantation and efficient preservation methods to maintain organ viability and improve transplant outcomes.

The key market trend for the Organ Preservation Market is the rising adoption of machine perfusion technology, which improves oxygen and nutrient delivery during preservation, enhances organ viability, extends preservation time, and supports better post-transplant outcomes.

North America accounted for the largest share of the Organ Preservation Market, supported by advanced healthcare infrastructure, high organ transplantation volumes, strong adoption of preservation technologies, substantial healthcare spending, and the presence of leading organ preservation technology providers.

Top Organ Preservation Companies

Organ Preservation Market Competitive Landscape

FAQs

What is the global market size of Organ Preservation Market?

Who are the key vendors in the Organ Preservation Market?

What is the key driver of Organ Preservation Market?

What is the key market trend for Organ Preservation Market?

Which region accounted for the largest share in Organ Preservation Market?

Request Free Customization